1. Home
  2. ALVR vs MOBX Comparison

ALVR vs MOBX Comparison

Compare ALVR & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVR
  • MOBX
  • Stock Information
  • Founded
  • ALVR 2013
  • MOBX 2020
  • Country
  • ALVR United States
  • MOBX United States
  • Employees
  • ALVR N/A
  • MOBX N/A
  • Industry
  • ALVR Biotechnology: Biological Products (No Diagnostic Substances)
  • MOBX
  • Sector
  • ALVR Health Care
  • MOBX
  • Exchange
  • ALVR Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • ALVR 48.8M
  • MOBX 46.9M
  • IPO Year
  • ALVR 2020
  • MOBX N/A
  • Fundamental
  • Price
  • ALVR $9.63
  • MOBX $1.26
  • Analyst Decision
  • ALVR
  • MOBX
  • Analyst Count
  • ALVR 0
  • MOBX 0
  • Target Price
  • ALVR N/A
  • MOBX N/A
  • AVG Volume (30 Days)
  • ALVR 22.4K
  • MOBX 507.2K
  • Earning Date
  • ALVR 03-14-2025
  • MOBX 02-18-2025
  • Dividend Yield
  • ALVR N/A
  • MOBX N/A
  • EPS Growth
  • ALVR N/A
  • MOBX N/A
  • EPS
  • ALVR N/A
  • MOBX N/A
  • Revenue
  • ALVR N/A
  • MOBX $9,326,000.00
  • Revenue This Year
  • ALVR N/A
  • MOBX N/A
  • Revenue Next Year
  • ALVR N/A
  • MOBX N/A
  • P/E Ratio
  • ALVR N/A
  • MOBX N/A
  • Revenue Growth
  • ALVR N/A
  • MOBX 1023.61
  • 52 Week Low
  • ALVR $7.96
  • MOBX $0.55
  • 52 Week High
  • ALVR $24.15
  • MOBX $3.62
  • Technical
  • Relative Strength Index (RSI)
  • ALVR 45.63
  • MOBX 47.25
  • Support Level
  • ALVR $9.55
  • MOBX $1.24
  • Resistance Level
  • ALVR $10.41
  • MOBX $1.41
  • Average True Range (ATR)
  • ALVR 0.44
  • MOBX 0.12
  • MACD
  • ALVR 0.05
  • MOBX 0.01
  • Stochastic Oscillator
  • ALVR 22.77
  • MOBX 37.14

About ALVR AlloVir Inc.

AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: